AI Article Synopsis
- Paget-Schroetter syndrome can lead to serious complications and permanent disability if not treated quickly.
- An emergency treatment protocol with thrombolysis and surgery showed 100% long-term success in immediate cases, while chronic cases also had a 100% success rate but often required additional measures like vein patches or stents.
- The study emphasizes urgent treatment for Paget-Schroetter syndrome to avoid lasting damage and recommends specific strategies for both acute and chronic cases.
Article Abstract
Background: Paget-Schroetter syndrome is a serious condition that if not treated promptly and properly leads to severe sequelae and permanent disability. In its late stage, chronic fibrous obliteration of the vein is rarely amenable to surgical treatment, except in very few select cases.
Methods: We treated 126 Paget-Schroetter syndrome patients (group I) by implementing an emergency protocol of thrombolysis by catheter-directed infusion, followed by immediate surgery through an anterior subclavian approach entailing (1) decompression of the thoracic inlet and (2) repairing the vein with a vein patch to reestablish its normal caliber. In addition, we treated another selective group of 81 patients (group II) for chronic fibrotic obstruction several months after their original event, but only when the inflow was adequate.
Results: Our acute emergency care resulted in a 100% long-term patency rate in group I, with no sequelae. The patency rate in group II was 100% as well, but in 74% a long vein patch, endovascular stents, or homograft implants were used.
Conclusions: Implementation of an emergency approach to treat Paget-Schroetter syndrome is highly recommended to prevent the delayed sequelae of permanent subclavian vein obliteration and disability. In chronic obstruction, when feasible, we recommend a long saphenous vein patch, followed by endovascular stent implant.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.athoracsur.2008.11.056 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Comprehensive Review of Catheter-Related Thrombosis.
J Clin Med
December 2024
Venous Thromboembolism Unit, Internal Medicine Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Catheter-related thrombosis (CRT) is a frequent and potentially serious complication associated with the widespread use of intravascular devices such as central venous catheters, including peripherally inserted central catheters and implantable port systems, pacemakers or implantable cardioverter-defibrillators. Although CRT management has been informed by guidelines extrapolated from lower extremity deep vein thrombosis (DVT), unique challenges remain due to the distinct anatomical, pathophysiological, and clinical characteristics of upper extremity DVT. Risk factors for CRT are multifactorial, encompassing patient-related characteristics such as cancer, prior venous thromboembolism, and infection, as well as catheter-specific factors like device type, lumens, and insertion site.
View Article and Find Full Text PDFTrends in the Epidemiology of Deep Vein Thrombosis and Pulmonary Embolism in Patients Undergoing Surgery.
Cureus
December 2024
Orthopaedics, University of Central Florida, Orlando, USA.
Objective This study aims to utilize the TriNetX database, a comprehensive global network, to improve our understanding of the frequency, demographic factors, and related comorbidities of surgical patients who develop venous thromboembolism (VTEs) events. Methods The global collaborative network in TriNetX was queried for all cases from January 1, 2017, through December 31, 2023. International Classification for Disease (ICD) diagnosis codes were used to define patient cohorts with deep vein thrombosis (DVT) of the upper or lower extremity or pulmonary embolism (PE).
View Article and Find Full Text PDFVenous thromboembolism treatment failure during use of factor Xa inhibitors-association with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertension.
Ann Med
December 2024
Heart and Lung Center, Cardiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Article Synopsis
- Factor Xa inhibitors are commonly used to treat venous thromboembolism (VTE), but a small percentage of patients experience treatment failure, prompting this study to explore the causes of recurrent VTE in those receiving FXaIs.
- The study included ten patients, mostly young adults with significant underlying VTE risk factors despite initial assessments suggesting unprovoked VTE, highlighting conditions like thoracic outlet syndrome contributing to their risks.
- Results indicated that treatment failure occurred within a few months, often leading to serious complications like chronic thromboembolic pulmonary hypertension, and emphasized the importance of tailored treatment strategies and careful risk evaluation for patients with recurrent VTE.
Article Synopsis
- A 57-year-old man developed deep vein thrombosis (DVT) in his left arm, decades after a clavicle fracture.
- A CT scan revealed that the left jugular vein was compressed due to a complication called pseudoarthrosis from the old fracture.
- The patient received treatment through thrombolysis and surgery to relieve the compression, emphasizing the need to investigate various causes for upper extremity DVT.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!